extended for analogs) GLP-3: Not well characterized Side Effects GLP-1: Nausea (common initially) Vomiting Diarrhea or constipation Reduced appetite Potential pancreatitis (rare) GLP-2: Generally well-tolerated Injection site reactions Abdominal pain or discomfort Nausea (less common than GLP-1) Fluid retention GLP-3: Unknown (no clinical use) Availability GLP-1: Widely available through prescription medications (semaglutide, liraglutide, etc.) and research peptides GLP-2: Available as teduglutide (Gattex/Revestive) by prescription
Tirzepatide dosing with B12 and other compounded combinations Many compounding pharmacies add vitamin B12 (cyanocobalamin or methylcobalamin) to tirzepatide formulations
Other supportive strategies to combine with a GLP-1 may include oral protein supplementation, collagen support, or even treatments like Sculptra and BodyTone to help offset skin laxity and muscle loss that can follow rapid weight reduction, Dr
Because of the rarity of the lesions, assembling a cohort study group to evaluate the different therapeutic regimens is difficult
Ongoing monitoring typically involves monthly or quarterly check-ins during dose titration, regular assessment of weight loss progress and tolerability, periodic lab work to monitor metabolic parameters, and screening for potential complications